Skip to main content

REACCIONES DE ACTIVACION C-H CATALIZADAS POR METALES DE TRANSICION EN SINTESIS Y FUNCIONALIZACION DE HETEROCICLOS. NUEVAS APLICACIONES SINTETICAS Y MODELOS COMPUTACIONALES

CTQ2016-74881-P

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DEL PAIS VASCO EUSKAL HERRIKO UNIBERTSITATEA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Prediction of Anti-Glioblastoma Drug-Decorated Nanoparticle Delivery Systems Using Molecular Descriptors and Machine Learning

  • Munteanu, Cristian-Robert
  • Gutiérrez-Asorey, Pablo
  • Blanes-Rodríguez, Manuel
  • Hidalgo-Delgado, Ismael
  • Blanco Liverio, María de Jesús
  • Galdo, Brais
  • Porto-Pazos, Ana B.
  • Gestal, M.
  • Arrasate, Sonia
  • González-Díaz, Humberto
This article belongs to the Special Issue Nanoformulations and Nano Drug Delivery, [Abstract] The theoretical prediction of drug-decorated nanoparticles (DDNPs) has become a very important task in medical applications. For the current paper, Perturbation Theory Machine Learning (PTML) models were built to predict the probability of different pairs of drugs and nanoparticles creating DDNP complexes with anti-glioblastoma activity. PTML models use the perturbations of molecular descriptors of drugs and nanoparticles as inputs in experimental conditions. The raw dataset was obtained by mixing the nanoparticle experimental data with drug assays from the ChEMBL database. Ten types of machine learning methods have been tested. Only 41 features have been selected for 855,129 drug-nanoparticle complexes. The best model was obtained with the Bagging classifier, an ensemble meta-estimator based on 20 decision trees, with an area under the receiver operating characteristic curve (AUROC) of 0.96, and an accuracy of 87% (test subset). This model could be useful for the virtual screening of nanoparticle-drug complexes in glioblastoma. All the calculations can be reproduced with the datasets and python scripts, which are freely available as a GitHub repository from authors., The APC was funded by IKERDATA, S.L. under grant 3/12/DP/2021/00102—Area 1: Development of innovative business projects, from Provincial Council of Vizcaya (BEAZ for the Creation of Innovative Business Innovative business ventures). This work is supported by the “Collaborative Project in Genomic Data Integration (CICLOGEN)” PI17/01826 funded by the Carlos III Health Institute, from the Spanish National Plan for Scientific and Technical Research and Innovation 2013–2016 and the European Regional Development Funds (FEDER)—“A way to build Europe”. This project was also supported by the General Directorate of Culture, Education and University Management of Xunta de Galicia (Ref. ED431G/01, ED431D 2017/16), the “Galician Network for Colorectal Cancer Research” (Ref. ED431D 2017/23), Competitive Reference Groups (Ref. ED431C 2018/49), and the Spanish Ministry of Economy and Competitiveness via funding of the unique installation BIOCAI (UNLC08-1E-002, UNLC13-13-3503) and the European Regional Development Funds (FEDER). Lastly, the authors also acknowledge research grants from the Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P), the Basque government (IT1045-16), and the kind support of Ikerbasque, Basque Foundation for Science and Zitek, Xunta de Galicia; ED431G/01, Xunta de Galicia; ED431D 2017/16, Xunta de Galicia; ED431D 2017/23, Xunta de Galicia; ED431C 2018/49, Eusko Jaurlaritza = Gobierno Vasco; IT1045-16
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Prediction of Breast Cancer Proteins Involved in Immunotherapy, Metastasis, and RNA-Binding Using Molecular Descriptors and Artifcial Neural Networks

  • López-Cortés, Andrés
  • Cabrera-Andrade, Alejandro
  • Vázquez-Naya, José
  • Pazos, A.
  • González-Díaz, Humberto
  • Paz-y-Miño, César
  • Guerrero, Santiago
  • Pérez-Castillo, Yunierkis
  • Tejera, Eduardo
  • Munteanu, Cristian-Robert
[Abstract] Breast cancer (BC) is a heterogeneous disease where genomic alterations, protein expression deregulation, signaling pathway alterations, hormone disruption, ethnicity and environmental determinants are involved. Due to the complexity of BC, the prediction of proteins involved in this disease is a trending topic in drug design. This work is proposing accurate prediction classifer for BC proteins using six sets of protein sequence descriptors and 13 machine-learning methods. After using a univariate feature selection for the mix of fve descriptor families, the best classifer was obtained using multilayer perceptron method (artifcial neural network) and 300 features. The performance of the model is demonstrated by the area under the receiver operating characteristics (AUROC) of 0.980±0.0037, and accuracy of 0.936±0.0056 (3-fold cross-validation). Regarding the prediction of 4,504 cancer-associated proteins using this model, the best ranked cancer immunotherapy proteins related to BC were RPS27, SUPT4H1, CLPSL2, POLR2K, RPL38, AKT3, CDK3, RPS20, RASL11A and UBTD1; the best ranked metastasis driver proteins related to BC were S100A9, DDA1, TXN, PRNP, RPS27, S100A14, S100A7, MAPK1, AGR3 and NDUFA13; and the best ranked RNA-binding proteins related to BC were S100A9, TXN, RPS27L, RPS27, RPS27A, RPL38, MRPL54, PPAN, RPS20 and CSRP1. This powerful model predicts several BC-related proteins that should be deeply studied to fnd new biomarkers and better therapeutic targets. Scripts can be downloaded at https://github.com/muntisa/ neural-networks-for-breast-cancer-proteins., This work was supported by a) Universidad UTE (Ecuador), b) the Collaborative Project in Genomic Data Integration (CICLOGEN) PI17/01826 funded by the Carlos III Health Institute from the Spanish National plan for Scientific and Technical Research and Innovation 2013-2016 and the European Regional Development Funds (FEDER) - “A way to build Europe”; c) the General Directorate of Culture, Education and University Management of Xunta de Galicia ED431D 2017/16 and “Drug Discovery Galician Network” Ref. ED431G/01 and the “Galician Network for Colorectal Cancer Research” (Ref. ED431D 2017/23); d) the Spanish Ministry of Economy and Competitiveness for its support through the funding of the unique installation BIOCAI (UNLC08-1E-002, UNLC13-13-3503) and the European Regional Development Funds (FEDER) by the European Union; e) the Consolidation and Structuring of Competitive Research Units - Competitive Reference Groups (ED431C 2018/49), funded by the Ministry of Education, University and Vocational Training of the Xunta de Galicia endowed with EU FEDER funds; f) research grants from Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P), Basque government (IT1045-16), and kind support of Ikerbasque, Basque Foundation for Science; and, g) Sociedad Latinoamericana de Farmacogenómica y Medicina Personalizada (SOLFAGEM), Xunta de Galicia; ED431D 2017/16, Xunta de Galicia; ED431G/01, Xunta de Galicia; ED431D 2017/23, Xunta de Galicia; ED431C 2018/49, Gobierno Vasco; IT1045-16
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Prediction of Antimalarial Drug-Decorated Nanoparticle Delivery Systems with Random Forest Models

  • Urista, Diana V.
  • Carrué, Diego B.
  • Otero, Iago
  • Arrasate, Sonia
  • Quevedo‐Tumailli, Viviana F.
  • Gestal, M.
  • González-Díaz, Humberto
  • Munteanu, Cristian-Robert
[Abstract]: Drug-decorated nanoparticles (DDNPs) have important medical applications. The current work combined Perturbation Theory with Machine Learning and Information Fusion (PTMLIF). Thus, PTMLIF models were proposed to predict the probability of nanoparticle–compound/drug complexes having antimalarial activity (against Plasmodium). The aim is to save experimental resources and time by using a virtual screening for DDNPs. The raw data was obtained by the fusion of experimental data for nanoparticles with compound chemical assays from the ChEMBL database. The inputs for the eight Machine Learning classifiers were transformed features of drugs/compounds and nanoparticles as perturbations of molecular descriptors in specific experimental conditions (experiment-centered features). The resulting dataset contains 107 input features and 249,992 examples. The best classification model was provided by Random Forest, with 27 selected features of drugs/compounds and nanoparticles in all experimental conditions considered. The high performance of the model was demonstrated by the mean Area Under the Receiver Operating Characteristics (AUC) in a test subset with a value of 0.9921 ± 0.000244 (10-fold cross-validation). The results demonstrated the power of information fusion of the experimental-centered features of drugs/compounds and nanoparticles for the prediction of nanoparticle–compound antimalarial activity. The scripts and dataset for this project are available in the open GitHub repository., This research and the APC were funded by Consolidation and Structuring of Competitive Research Units—Competitive Reference Groups (ED431C 2018/49) funded by the Ministry of Education, University and Vocational Training of Xunta de Galicia endowed with EU FEDER funds. This work was supported by the Collaborative Project in Genomic Data Integration (CICLOGEN)’’ PI17/01826 funded by the Carlos III Health Institute from the Spanish National plan for Scientific and Technical Research and Innovation 2013–2016 and the European Regional Development Funds (FEDER)—“A way to build Europe”. This project was also supported by the General Directorate of Culture, Education and University Management of Xunta de Galicia ED431D 2017/16 and “Drug Discovery Galician Network” Ref. ED431G/01 and the “Galician Network for Colorectal Cancer Research” (Ref. ED431D 2017/23), and finally by the Spanish Ministry of Economy and Competitiveness for its support through the funding of the unique installation BIOCAI (UNLC08-1E-002, UNLC13-13-3503) and the European Regional Development Funds (FEDER) by the European Union. Additional support was offered by the research grants from Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P), Basque government (IT1045-16), and kind support of Ikerbasque, Basque Foundation for Science., Xunta de Galicia; ED431C 2018/49, Xunta de Galicia; ED431G/01, Xunta de Galicia; ED431D 2017/23, Xunta de Galicia; ED431D 2017/16, Eusko Jaurlaritza = Gobierno Vasco; IT1045-16
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing

  • Cabrera-Andrade, Alejandro
  • López-Cortés, Andrés
  • Jaramillo-Koupermann, Gabriela
  • González-Díaz, Humberto
  • Pazos, A.
  • Munteanu, Cristian-Robert
  • Pérez-Castillo, Yunierkis
  • Tejera, Eduardo
[Abstract] Osteosarcoma is the most common type of primary malignant bone tumor. Although nowadays 5-year survival rates can reach up to 60–70%, acute complications and late effects of osteosarcoma therapy are two of the limiting factors in treatments. We developed a multi-objective algorithm for the repurposing of new anti-osteosarcoma drugs, based on the modeling of molecules with described activity for HOS, MG63, SAOS2, and U2OS cell lines in the ChEMBL database. Several predictive models were obtained for each cell line and those with accuracy greater than 0.8 were integrated into a desirability function for the final multi-objective model. An exhaustive exploration of model combinations was carried out to obtain the best multi-objective model in virtual screening. For the top 1% of the screened list, the final model showed a BEDROC = 0.562, EF = 27.6, and AUC = 0.653. The repositioning was performed on 2218 molecules described in DrugBank. Within the top-ranked drugs, we found: temsirolimus, paclitaxel, sirolimus, everolimus, and cabazitaxel, which are antineoplastic drugs described in clinical trials for cancer in general. Interestingly, we found several broad-spectrum antibiotics and antiretroviral agents. This powerful model predicts several drugs that should be studied in depth to find new chemotherapy regimens and to propose new strategies for osteosarcoma treatment., Universidad de Las Américas (Quito, Ecuador); ENF.RCA.18.01, Gobierno Vasco; IT1045-16)-2016–2021
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Multi-output chemometrics model for gasoline compounding

  • Bediaga, Harbil
  • Moreno, María Isabel
  • Arrasate, Sonia
  • Vilas-Vilela, José Luis
  • Orbe, Lucía
  • Unzueta, Elías
  • Pérez Mercader, Juan
  • González-Díaz, Humberto
Computational models may help to reduce research cost by predicting properties of alternative blends. Nowadays, most efforts focus on prediction of a few properties for sets of gasoline samples. However, there are no reports of models able for classification of gasoline samples with multiple output properties measured in real life refinery plants. In this work, Information Fusion (IF), Perturbation Theory (PT), and Machine Learning (ML) algorithm (IFPTML) was used to model real production data with >230,000 outcomes gathered from a petroleum refinery plant. IF-pre-processing phase assembled the working dataset with 44 physicochemical output properties vs. 574 input variables of 4 production lines distributed in 26 data blocks including 14 different streams and 23 operations carried out in the plant. PT-calculation phase quantifies the effect of perturbations (deviations) in all input variables using PT Operators. Last, in ML-analysis phase involved Linear Discriminant Analysis (LDA) and Artificial Neural Networks (ANN) models training. IFPTML-LDA model presented AUROC = 0.936 with overall Sensitivity Sn and Specificity Sp ≈ 84–91% for training and validation sets. In internal control experiment we obtained an IFPTML-FT-NIR model with similar Sn and Sp ≈ 86–97%, for >25,000 values of 16 properties measured FT-NIR technique; demonstrating the robustness of the algorithm to changes on the experimental techniques used. This model could be useful for the design of new alternatives blends (biofuels, refuse-derived fuels, etc.) with lower environmental impact., The authors acknowledge financial support from Basque government SPRI ELKARTEK program grant (KK-2019/00037). The authors also acknowledge partial financial support from research grants of Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P) and Basque Government (Eusko Jaurlaritza) consolidation groups grant (IT1045-16). G.D.H. personally acknowledges the support of IKERBASQUE, Basque Foundation for Science. J.P.-M. thanks Petronor S.A. for their support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecular docking, SAR analysis and biophysical approaches in the study of the antibacterial activity of ceramides isolated from Cissus incisa

  • Nocedo-Mena, Deyani
  • Arrasate, Sonia
  • Garza-González, Elvira
  • Rivas-Galindo, Verónica Mayela
  • Romo-Mancillas, Antonio
  • Munteanu, Cristian Robert
  • Sotomayor, Nuria
  • Lete, Esther
  • Barbolla, Iratxe
  • Martín, César
  • Camacho-Corona, María del Rayo
The developing of antibacterial resistance is becoming in crisis. In this sense, natural products play a fundamental role in the discovery of antibacterial agents with diverse mechanisms of action. Phytochemical investigation of Cissus incisa leaves led to isolation and characterization of the ceramides mixture (1): (8E)-2-(tritriacont-9-enoyl amino)-1,3,4-octadecanetriol-8-ene (1-I); (8E)-2-(2',3'-dihydroxyoctacosanoyl amino)-1,3,4-octadecanetriol-8-ene (1-II); (8E)-2-(2'-hydroxyheptacosanoyl amino)-1,3,4-octadecanetriol-8-ene (1-III); and (8E)-2-(-2'-hydroxynonacosanoyl amino)-1,3,4-octadecanetriol-8-ene (1-IV). Until now, this is the first report of the ceramides (1-I), (1-II), and (1-IV). The structures were elucidated using NMR and mass spectrometry analyses. Antibacterial activity of ceramides (1) and acetylated derivates (2) was evaluated against nine multidrug-resistant bacteria by Microdilution method. (1) showed the best results against Gram-negatives, mainly against carbapenems-resistant Acinetobacter baumannii with MIC = 50 μg/mL. Structure-activity analysis and molecular docking revealed interactions between plant ceramides with membrane proteins, and enzymes associated with biological membranes of Gram-negative bacteria, through hydrogen bonding of functional groups. Vesicular contents release assay showed the capacity of (1) to disturb membrane permeability detected by an increase of fluorescence probe over time. The membrane disruption is not caused for ceramides lytic action on cell membranes, according in vitro hemolyticactivity results. Combining SAR analysis, bioinformatics and biophysical techniques, and also experimental tests, it was possible to explain the antibacterial action of these natural ceramides., D.N.M, thanks financial support from CONACYT grant (No. 605522) and for Mobility Scholarships Abroad 2018 (291250)., E.L. acknowledge research grants from the Ministry of Economy and Competitiveness, MINECO, Spain (No. FEDER CTQ2016-74881-P), and the Basque government (No. IT1045-16). C.R.M. thanks to a) the Collaborative Project in Genomic Data Integration (CICLOGEN) PI17/01826 funded by the Carlos III Health Institute from the Spanish National plan for Scientific and Technical Research and Innovation 2013-2016 and the European Regional Development Funds (FEDER)-“A way to build Europe”; b) the Spanish Ministry of Economy and Competitiveness for its support through the funding of the unique installation BIOCAI (UNLC08-1E-002, UNLC13-13-3503) and the European Regional Development Funds (FEDER) by the European Union; c) the Consolidation and Structuring of Competitive Research Units - Competitive Reference Groups (ED431C 2018/49), funded by the Ministry of Education, University and Vocational Training of the Xunta de Galicia endowed with EU FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents

  • Barbolla, Iratxe
  • Hernández-Suárez, Leidi
  • Quevedo-Tumailli, Viviana
  • Nocedo-Mena, Deyani
  • Arrasate, Sonia
  • Dea-Ayuela, M. Auxiliadora
  • González-Díaz, Humberto
  • Sotomayor, Nuria
  • Lete, Esther
The development of new molecules for the treatment of leishmaniasis is, a neglected parasitic disease, is urgent as current anti-leishmanial therapeutics are hampered by drug toxicity and resistance. The pyrrolo[1,2-b]isoquinoline core was selected as starting point, and palladium-catalyzed Heck-initiated cascade reactions were developed for the synthesis of a series of C-10 substituted derivatives. Their in vitro leishmanicidal activity against visceral (L. donovani) and cutaneous (L. amazonensis) leishmaniasis was evaluated. The best activity was found, in general, for the 10-arylmethyl substituted pyrroloisoquinolines. In particular, 2ad (IC50 = 3.30 μM, SI > 77.01) and 2bb (IC50 = 3.93 μM, SI > 58.77) were approximately 10-fold more potent and selective than the drug of reference (miltefosine), against L. amazonensis on in vitro promastigote assays, while 2ae was the more active compound in the in vitro amastigote assays (IC50 = 33.59 μM, SI > 8.93). Notably, almost all compounds showed low cytotoxicity, CC50 > 100 μg/mL in J774 cells, highest tested dose. In addition, we have developed the first Perturbation Theory Machine Learning (PTML) algorithm able to predict simultaneously multiple biological activity parameters (IC50, Ki, etc.) vs. any Leishmania species and target protein, with high values of specificity (>98%) and sensitivity (>90%) in both training and validation series. Therefore, this model may be useful to reduce time and assay costs (material and human resources) in the drug discovery process., Ministerio de Economía y Competitividad (CTQ2016-74881-P), Ministerio de Ciencia e Innovación (PID2019-104148 GB-I00) and Gobierno Vasco (IT1045-16) are gratefully acknowledged for their financial support. I. B. wishes to thank Fundación Biofísica Bizkaia/Biofisika Bizkaia Fundazioa (FBB) for a postdoctoral grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pd(II)-Catalyzed Fujiwara-Moritani Reactions for the Synthesis and Functionalization of Substituted Coumarins

  • Ortiz de Elguea, Verónica
  • Carral-Menoyo, Asier
  • Simón-Vidal, Lorena
  • Martínez-Nunes, Mikel
  • Barbolla, Iratxe
  • Lete, Marta G.
  • Sotomayor, Nuria
  • Lete, Esther
Highly substituted coumarins, privileged and versatile scaffolds for bioactive natural products and fluorescence imaging, are obtained via a Pd(II)-catalyzed direct C-H alkenylation reaction (Fujiwara-Moritani reaction), which has emerged as a powerful tool for the construction and functionalization of heterocyclic compounds because of its chemical versatility and its environmental advantages. Thus, a selective 6-endo cyclization led to 4-substituted coumarins in moderate yields. Selected examples have been further functionalized in C3 through a second intermolecular C-H alkenylation reaction to give coumarin-acrylate hybrids, whose fluorescence spectra have been measured., Ministerio de Economía y Competitividad (FEDER CTQ2016-74881-P), Ministerio de Ciencia e Innovación (PID2019-104148GB-I00), and Gobierno Vasco (IT1045-16) are gratefully acknowledged for their financial support. A.C.-M. wishes to thank Gobierno Vasco for a grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Predicting Metabolic Reaction Networks with Perturbation-Theory Machine Learning (PTML) Models

  • Diéguez, Karel
  • Casañola, Gerardo
  • Green, James R.
  • Rasulev, Bakhtiyor
  • González-Díaz, Humberto
[Background] Checking the connectivity (structure) of complex Metabolic Reaction Networks (MRNs) models proposed for new microorganisms with promising properties is an important goal for chemical biology., [Objective] In principle, we can perform a hand-on checking (Manual Curation). However, this is a challenging task due to the high number of combinations of pairs of nodes (possible metabolic reactions)., [Results] The CPTML linear model obtained using the LDA algorithm is able to discriminate nodes (metabolites) with the correct assignation of reactions from incorrect nodes with values of accuracy, specificity, and sensitivity in the range of 85-100% in both training and external validation data series., [Methods] In this work, we used Combinatorial Perturbation Theory and Machine Learning techniques to seek a CPTML model for MRNs >40 organisms compiled by Barabasis’ group. First, we quantified the local structure of a very large set of nodes in each MRN using a new class of node index called Markov linear indices fk. Next, we calculated CPT operators for 150000 combinations of query and reference nodes of MRNs. Last, we used these CPT operators as inputs of different ML algorithms., [Conclusion] Meanwhile, PTML models based on Bayesian network, J48-Decision Tree and Random Forest algorithms were identified as the three best non-linear models with accuracy greater than 97.5%. The present work opens the door to the study of MRNs of multiple organisms using PTML models., G.M.C.M acknowledges the partial financial support of the Carleton University grant. This work was also supported in part by the National Science Foundation through the ND EPSCoR Award #IIA-1355466 and by the State of North Dakota. G.D.H personally acknowledges financial support from grants MINECO (CTQ2013-41229-P) - 2014 – 2016 and MINECO (CTQ2016-74881-P) - 2017 – 2019 of Spain government and grant (IT1045-16) - 2016 – 2021 of Basque Government., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prediction of Anti-Glioblastoma Drug-Decorated Nanoparticle Delivery Systems Using Molecular Descriptors and Machine Learning

  • Munteanu, Cristian Robert
  • Gutiérrez-Asorey, Pablo
  • Blanes-Rodríguez, Manuel
  • Hidalgo-Delgado, Ismael
  • Blanco Liverio, María de Jesús
  • Castiñeiras Galdo, Brais
  • Porto-Pazos, Ana B.
  • Gestal, Marcos
  • Arrasate, Sonia
  • González-Díaz, Humberto
The theoretical prediction of drug-decorated nanoparticles (DDNPs) has become a very important task in medical applications. For the current paper, Perturbation Theory Machine Learning (PTML) models were built to predict the probability of different pairs of drugs and nanoparticles creating DDNP complexes with anti-glioblastoma activity. PTML models use the perturbations of molecular descriptors of drugs and nanoparticles as inputs in experimental conditions. The raw dataset was obtained by mixing the nanoparticle experimental data with drug assays from the ChEMBL database. Ten types of machine learning methods have been tested. Only 41 features have been selected for 855,129 drug-nanoparticle complexes. The best model was obtained with the Bagging classifier, an ensemble meta-estimator based on 20 decision trees, with an area under the receiver operating characteristic curve (AUROC) of 0.96, and an accuracy of 87% (test subset). This model could be useful for the virtual screening of nanoparticle-drug complexes in glioblastoma. All the calculations can be reproduced with the datasets and python scripts, which are freely available as a GitHub repository from authors., The APC was funded by IKERDATA, S.L. under grant 3/12/DP/2021/00102, This work is supported by the “Collaborative Project in Genomic Data Integration (CICLOGEN)” PI17/01826 funded by the Carlos III Health Institute, from the Spanish National Plan for Scientific and Technical Research and Innovation 2013–2016 and the European Regional Development Funds (FEDER)—“A way to build Europe”. This project was also supported by the General Directorate of Culture, Education and University Management of Xunta de Galicia (Ref. ED431G/01, ED431D 2017/16), the “Galician Network for Colorectal Cancer Research” (Ref. ED431D 2017/23), Competitive Reference Groups (Ref. ED431C 2018/49), and the Spanish Ministry of Economy and Competitiveness via funding of the unique installation BIOCAI (UNLC08-1E-002, UNLC13-13-3503) and the European Regional Development Funds (FEDER). Lastly, the authors also acknowledge research grants from the Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P), the Basque government (IT1045-16), and the kind support of Ikerbasque, Basque Foundation for Science and Zitek., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML)

  • Sampaio-Dias, Ivo E.
  • Rodríguez-Borges, José E.
  • Yáñez-Pérez, Víctor
  • Arrasate, Sonia
  • Llorente, Javier
  • Brea, José M.
  • Bediaga, Harbil
  • Viña, Dolores
  • Loza, María Isabel
  • Caamaño, Olga
  • García-Mera, Xerardo
  • González-Díaz, Humberto
This work describes the synthesis and pharmacological evaluation of 2-furoyl-based Melanostatin (MIF-1) peptidomimetics as dopamine D2 modulating agents. Eight novel peptidomimetics were tested for their ability to enhance the maximal effect of tritiated N-propylapomorphine ([3H]-NPA) at D2 receptors (D2R). In this series, 2-furoyl-l-leucylglycinamide (6a) produced a statistically significant increase in the maximal [3H]-NPA response at 10 pM (11 ± 1%), comparable to the effect of MIF-1 (18 ± 9%) at the same concentration. This result supports previous evidence that the replacement of proline residue by heteroaromatic scaffolds are tolerated at the allosteric binding site of MIF-1. Biological assays performed for peptidomimetic 6a using cortex neurons from 19-day-old Wistar-Kyoto rat embryos suggest that 6a displays no neurotoxicity up to 100 μM. Overall, the pharmacological and toxicological profile and the structural simplicity of 6a makes this peptidomimetic a potential lead compound for further development and optimization, paving the way for the development of novel modulating agents of D2R suitable for the treatment of CNS-related diseases. Additionally, the pharmacological and biological data herein reported, along with >20â000 outcomes of preclinical assays, was used to seek a general model to predict the allosteric modulatory potential of molecular candidates for a myriad of target receptors, organisms, cell lines, and biological activity parameters based on perturbation theory (PT) ideas and machine learning (ML) techniques, abbreviated as ALLOPTML. By doing so, ALLOPTML shows high specificity Sp = 89.2/89.4%, sensitivity Sn = 71.3/72.2%, and accuracy Ac = 86.1%/86.4% in training/validation series, respectively. To the best of our knowledge, ALLOPTML is the first general-purpose chemoinformatic tool using a PTML-based model for the multioutput and multicondition prediction of allosteric compounds, which is expected to save both time and resources during the early drug discovery of allosteric modulators., This research was funded by Fundação para a Ciência e Tecnologia (FCT, Portugal), through grants UIDB/50006/2020 (to LAQV-REQUIMTE Research Unit) and for project grants PTDC/BIA-MIB/29059/2017 and PEst-OE/QUI/UI0674/2013. This work was also supported by the Collaborative Project of Genomic Data Integration (CICLOGEN)., The support of Ikerbasque, Basque Foundation for Science and the research grants from Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016–74881-P), and Basque government (IT1045–16) are also acknowledged. The financial support (ED431G 2019/02) from the Xunta de Galicia (Centro singular de investigación de Galicia accreditation 2019–2022) and the European Union (European Regional Development Fund—ERDF) is gratefully acknowledged. I.E.S.-D. thanks FCT for the doctoral grant SFRH/BD/93632/2013. X.G.-M. thanks Xunta de Galicia for financial support (GPC2014/003)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MCDCalc: Markov Chain Molecular Descriptors Calculator for Medicinal Chemistry

  • Carracedo-Reboredo, Paula
  • Corona, Ramiro
  • Martínez-Nunes, Mikel
  • Fernández-Lozano, Carlos
  • Tsiliki, Georgia
  • Sarimveis, Haralambos
  • Aranzamendi, Eider
  • Arrasate, Sonia
  • Sotomayor, Nuria
  • Lete, Esther
  • Munteanu, Cristian Robert
  • González-Díaz, Humberto
[Aims] Cheminformatics models are able to predict different outputs (activity, property, chemical reactivity) in single molecules or complex molecular systems (catalyzed organic synthesis, metabolic reactions, nanoparticles, etc.)., [Background] Cheminformatics models are able to predict different outputs (activity, property, chemical reactivity) in single molecules or complex molecular systems (catalyzed organic synthesis, metabolic reactions, nanoparticles, etc.)., [Objective] Objective: Cheminformatics prediction of complex catalytic enantioselective reactions is a major goal in organic synthesis research and chemical industry. Markov Chain Molecular Descriptors (MCDs) have been largely used to solve Cheminformatics problems. There are different types of Markov chain descriptors such as Markov-Shannon entropies (Shk), Markov Means (Mk), Markov Moments (πk), etc. However, there are other possible MCDs that have not been used before. In addition, the calculation of MCDs is done very often using specific software not always available for general users and there is not an R library public available for the calculation of MCDs. This fact, limits the availability of MCMDbased Cheminformatics procedures., [Methods] We studied the enantiomeric excess ee(%)[Rcat] for 324 α-amidoalkylation reactions. These reactions have a complex mechanism depending on various factors. The model includes MCDs of the substrate, solvent, chiral catalyst, product along with values of time of reaction, temperature, load of catalyst, etc. We tested several Machine Learning regression algorithms. The Random Forest regression model has R2 > 0.90 in training and test. Secondly, the biological activity of 5644 compounds against colorectal cancer was studied., [Result] We developed very interesting model able to predict with Specificity and Sensitivity 70-82% the cases of preclinical assays in both training and validation series., [Conclusion] The work shows the potential of the new tool for computational studies in organic and medicinal chemistry., Spanish Ministry of Economy and Competitiveness (FEDER CTQ2016-74881-P) and (CTQ2013-41229-P) and Basque Government (IT1045-16) are gratefully acknowledged for their financial support. This work is supported by “Collaborative Project in Genomic Data Integration (CICLOGEN)” PI17/01826 funded by the Carlos III Health Institute from the Spanish National Plan for Scientific and Technical Research and Innovation 2013-2016 and the European Regional Development Funds (FEDER). This project as also supported by the General Directorate of Culture, Education and University Management of Xunta de Galicia ED431D 2017/16 and “Drug Discovery Galician Network” Ref. ED431G/01 and the “Galician Network for Colorectal Cancer Research” (Ref. ED431D 2017/23) and finally by the Spanish Ministry of Economy and Competitiveness for its support with the funding of the unique installation BIOCAI (UNLC08-1E-002, UNLC13-13-3503) and the European Regional Development Funds (FEDER) by the European Union., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

New Experimental and Computational Tools for Drug Discovery. From Old Way to New Series - Part-X

  • Montemore, Matthew M.
  • Santana, Ricardo
  • Fall, Yagamare
  • González-Díaz, Humberto
The series began with several special issues edited by many researchers worldwide and co-edited/supervised or invited by Prof. Gonzalez-Diaz H. (CTMC Enabling Tech Editor, Co-EIC, Europe Editor) [...], The authors acknowledge grants from MINECO (CTQ2016-74881-P) and Basque Government (No. IT1045-16, No. IT1066-16)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Perturbation-Theory Machine Learning (PTML) Multilabel Model of the ChEMBL Dataset of Preclinical Assays for Antisarcoma Compounds

  • Cabrera-Andrade, Alejandro
  • López-Cortés, Andrés
  • Munteanu, Cristian Robert
  • Pazos, Alejandro
  • Pérez-Castillo, Yunierkis
  • Tejera, Eduardo
  • Arrasate, Sonia
  • González-Díaz, Humberto
Sarcomas are a group of malignant neoplasms of connective tissue with a different etiology than carcinomas. The efforts to discover new drugs with antisarcoma activity have generated large datasets of multiple preclinical assays with different experimental conditions. For instance, the ChEMBL database contains outcomes of 37,919 different antisarcoma assays with 34,955 different chemical compounds. Furthermore, the experimental conditions reported in this dataset include 157 types of biological activity parameters, 36 drug targets, 43 cell lines, and 17 assay organisms. Considering this information, we propose combining perturbation theory (PT) principles with machine learning (ML) to develop a PTML model to predict antisarcoma compounds. PTML models use one function of reference that measures the probability of a drug being active under certain conditions (protein, cell line, organism, etc.). In this paper, we used a linear discriminant analysis and neural network to train and compare PT and non-PT models. All the explored models have an accuracy of 89.19-95.25% for training and 89.22-95.46% in validation sets. PTML-based strategies have similar accuracy but generate simplest models. Therefore, they may become a versatile tool for predicting antisarcoma compounds., The authors acknowledge research grants from Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P), and Basque government (IT1045-16). The authors also acknowledge the support of Ikerbasque, Basque Foundation for Science. This work was supported by Universidad de Las Américas and the Collaborative Project in Genomic Data Integration (CICLOGEN) PI17/01826 funded by the Carlos III Health Institute from the Spanish National Plan for Scientific and Technical Research and Innovation 2013–2016 and the European Regional Development Funds (FEDER)–“A way to build Europe”. This project was also supported by the General Directorate of Culture, Education and University Management of Xunta de Galicia ED431D 2017/16 and “Drug Discovery Galician Network” ref. ED431G/01 and the “Galician Network for Colorectal Cancer Research” (ref. ED431D 2017/23) and finally by the Spanish Ministry of Economy and Competitiveness for its support through the funding of the unique installation BIOCAI (UNLC08-1E-002, UNLC13-13-3503) and the European Regional Development Funds (FEDER) by the European Union. Additional support was offered by the Consolidation and Structuring of Competitive Research Units–Competitive Reference Groups (ED431C 2018/49), funded by the Ministry of Education, University and Vocational Training of the Xunta de Galicia endowed with EU FEDER funds, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Predicting coated-nanoparticle drug release systems with perturbation-theory machine learning (PTML) models

  • Santana, Ricardo
  • Zuluaga, Robin
  • Gañán, Piedad
  • Arrasate, Sonia
  • Onieva, Enrique
  • González-Díaz, Humberto
Nanoparticles (NPs) decorated with coating agents (polymers, gels, proteins, etc.) form Nanoparticle Drug Delivery Systems (DDNS), which are of high interest in nanotechnology and biomaterials science. There have been increasing reports of experimental data sets of biological activity, toxicity, and delivery properties of DDNS. However, these data sets are still dispersed and not as large as the datasets of DDNS components (NP and drugs). This has prompted researchers to train Machine Learning (ML) algorithms that are able to design new DDNS based on the properties of their components. However, most ML models reported up to date predictions of the specific activities of NP or drugs over a determined target or cell line. In this paper, we combine Perturbation Theory and Machine Learning (PTML algorithm) to train a model that is able to predict the best components (NP, coating agent, and drug) for DDNS design. In so doing, we downloaded a dataset of >30 000 preclinical assays of drugs from ChEMBL. We also downloaded an NP data set formed by preclinical assays of coated Metal Oxide Nanoparticles (MONPs) from public sources. Both the drugs and NP datasets of preclinical assays cover multiple conditions of assays that can be listed as two arrays, namely, cjdrug and cjNP. The cjdrug array includes >504 biological activity parameters (c0drug), >340 target proteins (c1drug), >650 types of cells (c2drug), >120 assay organisms (c3drug), and >60 assay strains (c4drug). On the other hand, the cjNP array includes 3 biological activity parameters (c0NP), 40 types of proteins (c1NP), 10 shapes of nanoparticles (c2NP), 6 assay media (c3NP), and 12 coating agents (c4NP). After downloading, we pre-processed both the data sets by separate calculation PT operators that are able to account for changes (perturbations) in the drug, coating agents, and NP chemical structure and/or physicochemical properties as well as for the assay conditions. Next, we carry out an information fusion process to form a final dataset of above 500 000 DDNS (drug + MONP pairs). We also trained other linear and non-linear PTML models using R studio scripts for comparative purposes. To the best of our knowledge, this is the first multi-label PTML model that is useful for the selection of drugs, coating agents, and metal or metal-oxide nanoparticles to be assembled in order to design new DDNS with optimal activity/toxicity profiles., R. S. C. thanks COLCIENCIAS scholarship for the doctorate studies; “Convocatoria para Doctorado Nacional 757” from 2017. This original research is part of the project “Investigación en Derecho Internacional y Nanotecnología” registered in the Research Centre of Universidad Pontificia Bolivariana with register number 766B-06/17-37. Special gratitude is extended to CYTED NANOCELIA network. The authors acknowledge research grants from Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P) and Basque government (IT1045-16). The authors also acknowledge the support of Ikerbasque, Basque Foundation for Science., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PTML Model for Selection of Nanoparticles, Anticancer Drugs, and Vitamins in the Design of Drug-Vitamin Nanoparticle Release Systems for Cancer Cotherapy

  • Santana, Ricardo
  • Zuluaga, Robin
  • Gañán, Piedad
  • Arrasate, Sonia
  • Onieva, Enrique
  • Montemore, Matthew M.
  • González-Díaz, Humberto
Nanosystems are gaining momentum in pharmaceutical sciences because of the wide variety of possibilities for designing these systems to have specific functions. Specifically, studies of new cancer cotherapy drug-vitamin release nanosystems (DVRNs) including anticancer compounds and vitamins or vitamin derivatives have revealed encouraging results. However, the number of possible combinations of design and synthesis conditions is remarkably high. In addition, a large number of anticancer and vitamin derivatives have been already assayed, but a notably less number of cases of DVRNs were assayed as a whole (with the anticancer compound and the vitamin linked to them). Our approach combines with the perturbation theory and machine learning (PTML) model to predict the probability of obtaining an interesting DVRN by changing the anticancer compound and/or the vitamin present in a DVRN that is already tested for other anticancer compounds or vitamins that have not been tested yet as part of a DVRN. In a previous work, we built a linear PTML model useful for the design of these nanosystems. In doing so, we used information fusion (IF) techniques to carry out data enrichment of DVRN data compiled from the literature with the data for preclinical assays of vitamins from the ChEMBL database. The design features of DVRNs and the assay conditions of nanoparticles (NPs) and vitamins were included as multiplicative PT operators (PTOs) to the system, which indicates the importance of these variables. However, the previous work omitted experiments with nonlinear ML techniques and different types of PTOs such as metric-based PTOs. More importantly, the previous work does not consider the structure of the anticancer drug to be included in the new DVRNs. In this work, we are going to accomplish three main objectives (tasks). In the first task, we found a new model, alternative to the one published before, for the rational design of DVRNs using metric-based PTOs. The most accurate PTML model was the artificial neural network model, which showed values of specificity, sensitivity, and accuracy in the range of 90-95% in training and external validation series for more than 130,000 cases (DVRNs vs ChEMBL assays). Furthermore, in the second task, we used IF techniques to carry out data enrichment of our previous data set. In doing so, we constructed a new working data set of >970,000 cases with the data of preclinical assays of DVRNs, vitamins, and anticancer compounds from the ChEMBL database. All these assays have multiple continuous variables or descriptors dk and categorical variables cj (conditions of the assays) for drugs (dack, cacj), vitamins (dvk, cvj), and NPs (dnk, cnj). These data include >20,000 potential anticancer compounds with >270 protein targets (cac1), >580 assay cell organisms (cac2), and so forth. Furthermore, we include >36,000 assay vitamin derivatives in >6200 types of cells (c2vit), >120 assay organisms (c3vit), >60 assay strains (c4vit), and so forth. The enriched data set also contains >20 types of DVRNs (c5n) with 9 NP core materials (c4n), 8 synthesis methods (c7n), and so forth. We expressed all this information with PTOs and developed a qualitatively new PTML model that incorporates information of the anticancer drugs. This new model presents 96-97% of accuracy for training and external validation subsets. In the last task, we carried out a comparative study of ML and/or PTML models published and described how the models we are presenting cover the gap of knowledge in terms of drug delivery. In conclusion, we present here for the first time a multipurpose PTML model that is able to select NPs, anticancer compounds, and vitamins and their conditions of assay for DVRN design., R.S. thanks COLCIENCIAS scholarship for the doctorate studies: “Convocatoria para Doctorado Nacional 757” from 2017. This original research is part of the project “Investigación en Derecho Internacional y Nanotecnología” registered in the Research Centre of Universidad Pontificia Bolivariana with register number 766B-06/17-37. Special gratitude is extended to CYTED NANOCELIA network. The authors acknowledge research grants from the Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P), and Basque government (IT1045-16). The authors also acknowledge the support of Ikerbasque, Basque Foundation for Science., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PTML Multi-Label Algorithms: Models, Software, and Applications

  • Ortega Tenezaca, Bernabé
  • Quevedo-Tumailli, Viviana
  • Bediaga, Harbil
  • Collados, Jon
  • Arrasate, Sonia
  • Madariaga, Gotzon
  • Munteanu, Cristian Robert
  • Cordeiro, M. Natália D. S.
  • González-Díaz, Humberto
By combining Machine Learning (ML) methods with Perturbation Theory (PT), it is possible to develop predictive models for a variety of response targets. Such combination often known as Perturbation Theory Machine Learning (PTML) modeling comprises a set of techniques that can handle various physical, and chemical properties of different organisms, complex biological or material systems under multiple input conditions. In so doing, these techniques effectively integrate a manifold of diverse chemical and biological data into a single computational framework that can then be applied for screening lead chemicals as well as to find clues for improving the targeted response(s). PTML models have thus been extremely helpful in drug or material design efforts and found to be predictive and applicable across a broad space of systems. After a brief outline of the applied methodology, this work reviews the different uses of PTML in Medicinal Chemistry, as well as in other applications. Finally, we cover the development of software available nowadays for setting up PTML models from large datasets., H.G.-D. and S.A.G. acknowledge financial support from grants MINECO (CTQ2013-41229-P) - 2014−2016 and MINECO (CTQ2016-74881-P) - 2017−2019 of Spain government. H.G.-D. and S.A.G. also acknowledge financial support from ELKARTEK SPRI grants (KK-2019/00037 and KK-2020/00110) and grant (IT1045-16) - 2016−2021) and of Basque Government. M.N.D.S.C. thanks also the financial support of project UID/QUI/50006/2020 with funding from FCT/MCTES through national funds. This project was also supported by the General Directorate of Culture, Education and University Management of Xunta de Galicia (Ref. ED431G/01, ED431D 2017/16)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [35S]GTPγS Binding Assays

  • Diez Alarcia, Rebeca
  • Yáñez-Pérez, Víctor
  • Muneta Arrate, Itziar
  • Arrasate, Sonia
  • Lete, Esther
  • Meana, J. Javier
  • González Díaz, Humbert
G-protein-coupled receptors (GPCRs), also known as 7-transmembrane receptors, are the single largest class of drug targets. Consequently, a large amount of preclinical assays having GPCRs as molecular targets has been released to public sources like the Chemical European Molecular Biology Laboratory (ChEMBL) database. These data are also very complex covering changes in drug chemical structure and assay conditions like c0 = activity parameter (Ki, IC50, etc.), c1 = target protein, c2 = cell line, c3 = assay organism, etc., making difficult the analysis of these databases that are placed in the borders of a Big Data challenge. One of the aims of this work is to develop a computational model able to predict new GPCRs targeting drugs taking into consideration multiple conditions of assay. Another objective is to perform new predictive and experimental studies of selective 5-HTA2 receptor agonist, antagonist, or inverse agonist in human comparing the results with those from the literature. In this work, we combined Perturbation Theory (PT) and Machine Learning (ML) to seek a general PTML model for this data set. We analyzed 343 738 unique compounds with 812 072 end points (assay outcomes), with 185 different experimental parameters, 592 protein targets, 51 cell lines, and/or 55 organisms (species). The best PTML linear model found has three input variables only and predicted 56 202/58 653 positive outcomes (sensitivity = 95.8%) and 470 230/550 401 control cases (specificity = 85.4%) in training series. The model also predicted correctly 18 732/19 549 (95.8%) of positive outcomes and 156 739/183 469 (85.4%) of cases in external validation series. To illustrate its practical use, we used the model to predict the outcomes of six different 5-HT2A receptor drugs, namely, TCB-2, DOI, DOB, altanserin, pimavanserin, and nelotanserin, in a very large number of different pharmacological assays. 5-HT2A receptors are altered in schizophrenia and represent drug target for antipsychotic therapeutic activity. The model correctly predicted 93.83% (76 of 86) experimental results for these compounds reported in ChEMBL. Moreover, [35S]GTPγS binding assays were performed experimentally with the same six drugs with the aim of determining their potency and efficacy in the modulation of G-proteins in human brain tissue. The antagonist ketanserin was included as inactive drug with demonstrated affinity for 5-HT2A/C receptors. Our results demonstrate that some of these drugs, previously described as serotonin 5-HT2A receptor agonists, antagonists, or inverse agonists, are not so specific and show different intrinsic activity to that previously reported. Overall, this work opens a new gate for the prediction of GPCRs targeting compounds., This work was funded by the Basque Government (ELKARTEK Programme, KK-2017/00023). The authors also acknowledge research grants from Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P and SAF-2017-88126R) and Basque Government (IT1045-16 and IT1211-19)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Designing nanoparticle release systems for drug-vitamin cancer co-therapy with multiplicative perturbation-theory machine learning (PTML) models

  • Santana, Ricardo
  • Zuluaga, Robin
  • Gañán, Piedad
  • Arrasate, Sonia
  • Onieva, Enrique
  • González-Díaz, Humberto
Nano-systems for cancer co-therapy including vitamins or vitamin derivatives have showed adequate results to continue with further research studies to better understand them. However, the number of different combinations of drugs, vitamins, nanoparticle types, coating agents, synthesis conditions, and system types (nanocapsules, micelles, etc.) to be tested is very large generating a high cost in experimentations. In this context, there are reports of large datasets of preclinical assays of compounds (like in the ChEMBL database) and increasing but yet limited reports of experimental measurements of nano-systems per se. On the other hand, Machine Learning is gaining momentum in Nanotechnology and Pharmaceutical Sciences as a tool for rational design of new drugs and drug-release nano-systems. In this work, we propose to combine Perturbation Theory principles and Machine Learning to develop a PTML model for rational selection of the components of cancer co-therapy drug-vitamin release nano-systems (DVRNs). In doing so, we apply information fusion techniques with 2 data sets: (1) a large ChEMBL dataset of >36 000 preclinical assays of vitamin derivatives and a new dataset of >1000 outcomes of DVRNs, collected herein from the literature for the first time. The ChEMBL dataset used covers a considerable number of assay conditions (cjvit) each one with multiple levels. These conditions included >504 biological activity parameters (c0vit), >340 types of proteins (c1vit), >650 types of cells (c2vit), >120 assay organisms (c3vit), >60 assay strains (c4vit). Regarding the DVRNs, there are 25 different types of nano-systems (njn), with up to 16 conditions (cjn) including also different levels such as 8 biological activity parameters (c0n), 9 raw nanomaterials (c4n), 15 assay cells (c11n), etc. In the first stage, we used Moving Average operators to quantify the perturbations (deviations) in all input variables with respect to the conditions. After that, we used multiplicative PT operators to carry out data fusion, and dimension reduction, and Linear Discriminant Analysis (LDA) to seek the PTML model. The best PTML model found showed values of specificity, sensitivity, and accuracy in the range of 83-88% in training and external validation series for >130 000 cases (DVRNs vs. ChEMBL data pairs) formed after data fusion. To the best of our knowledge, this is the first general purpose model for the rational design of DVRNs for cancer co-therapy., R. S. C. thanks COLCIENCIAS for a scholarship for the doctorate studies; “Convocatoria para Doctorado Nacional 757” from 2017. This original research is part of the project “Investigación en Derecho Internacional y Nanotecnpología” registered in the Research Centre of Universidad Pontificia Bolivariana with register number 766B-06/17-37. Special gratitude is extended to CYTED NANOCELIA network. The authors acknowledge research grants from Ministry of Economy and Competitiveness, MINECO, Spain (FEDER CTQ2016-74881-P) and Basque government (IT1045-16). The authors also acknowledge the support of Ikerbasque, Basque Foundation for Science., Peer reviewed